After an independent review, ongoing clinical trials investigating the safety of fasinumab for treating hip or knee OA will discontinue the use of higher fasinumab doses…
Search results for: hip OA
2014 ACR/ARHP Annual Meeting: Alive and Growing
Bone disorders play role in development of osteoarthritis pain, progression
New Insights into CPPD
Progress in research, outcomes, diagnosis, and treatment of calcium pyrophosphate dihydrate crystal deposition disease
A&R and AC&R Abstracts: Bisphosphonates
Want to learn more about bisphosphonates and fractures? Check out these abstracts from Arthritis & Rheumatism and Arthritis Care & Research.
Drug Updates
Information on New Approvals and Medication Safety
Are NSAIDS Even Less Safe Than We Thought?
Recent meta-analysis points to MI risks, but many questions remain
Get the Most Out of Joint Replacement
Exercise can improve the outcomes in hip and knee replacement surgery
Ekemini A. Ogbu, MD, MSc, FAAP, Leads the Pediatric Rheumatology Committee
The new chair of the ACR’s Pediatric Rheumatology Committee, Ekemini A. Ogbu, MD, MSc, FAAP, describes how helping children and families navigate complex care brings a sense of fulfillment, purpose and “just joy.”
How RheumPAC Is Supporting You in Uncertain Times
As the new administration enacts policies that impact you and the care you provide to your patients, RheumPAC is working to inform key lawmakers of the downstream effects of these unilateral actions. Learn more about RheumPAC’s role in the ACR’s advocacy efforts.
Rheumatologist Elected to Key AMA Committee That Helps CMS Set Medicare Reimbursements
Luke Barré, MD, MPH, RhMSUS, has been elected to the American Medical Association’s Relative Value Update Committee. He is the second rheumatologist to hold the seat in recent years and will ensure representation of the specialty during valuation of physician services.
- « Previous Page
- 1
- …
- 31
- 32
- 33
- 34
- 35
- …
- 324
- Next Page »